Professional Documents
Culture Documents
The Round Up
30 November 2009
Issue No. 228
The Round Up is a comprehensive daily note produced by the RBS Warrants
team providing an overview of market movements along with quality ideas for
warrant traders and investors.
In today’s issue
Global Market Action Scoreboard, commentary
Aussie Market Action SPI Comment, Events & Dividends
UGL (UGLKZC) MINI Trading Buy – Top sector pick
BXB (BXBKZG) MINI Trading Buy – Recovery Story
TLS (TLSSZX) SFI Investment Buy – Regulatory risk falling
Round Up Corner Banks Update – ANZ,CBA,NAB,WBC
Equities
Commodities
Overnight Commentary
United States Commentary
The sell off from the Dubai World news was not as dramatic in the US, as it was either here or across UK/Europe. Lows were set on
the open in a shortened session and although risk aversion was certainly the trade of the day and all Dow constituents finished in the
red, the 154pt deficit was arguably not as bad as most had been bracing for. Elsewhere, the Nasdaq and S&P both gave back 1.7%.
Financials - Not surprisingly financials were among the hardest hit and within the space, investment banks felt most of the pain. BofA
down 3%(Dow's worst), Morgan Stanley dropped 2.9%,Goldmans 2.8% and JP's finished 2% lower as the market attempted to quantify
the US financial sectors exposure to Dubai World.
Cyclicals - Resource stocks were the other big loser behind the banks, Alcoa off nearly 3% on the back of a tough night on the LME
and a general aversion for cyclical exposure. Exxon and Chevron followed the oil price lower, down 2.1% and 1.9% respectively and
two of the larger point takers from the Dow.
Market Barometers - Filling the rest of the gaps in the Dow's bottom 10, the bellwethers viewed as a gauge of US economic health
gave back more ground. Caterpillar down 2.7%, Dupont 2.1%, HP and Microsoft down 2% and 1.9% respectively.
FX/Bonds - A reasonably clear flight to safety on Friday, yields on the 2&10yr down c6pbs and 3.5bps for the 30yr and although it was
hardly a rush to buy USD's, there was a noted absence of any real selling, the DXY index stable and the AUD trading sub 91c.
Commodites Commentary
Copper futures fell the most in four weeks and the oil price was also weaker , giving up 2.5%. The weakness is the result of the
nervousness that is still present from the Dubai situation and whilst the financial sector experienced some recovery in Europe it will
likely take a little longer for the USD to move past the negative sentiment.
SPI Commentary
The SPI traded down 122pts to 4596 on Friday. Overnight the SPI traded up 37pts to 4633.
*SPI report taken from the 9:50am open to the 4:30pm close on the previous trading day. Charts taken from IRESS
Monday AUS TDMI inflation gauge, HIA new home sales, RBA private sector credit, Wages bill, small business profits, company
profits, real business sales, real business inventories
US Chicago PMI, Milwaukee NAPM, Dallas Fed Manufacturing
Tuesday AUS AIG/PWC manufacturing PMI, Building approvals, Real public final demand, RBA cash rate decision
US ISM, Construction spending, Pending home sales
Wednesday AUS
US ADP employment report
Thursday AUS Nominal retail trade
US Non farm productivity
Friday AUS
US Non-farm payrolls, unemployment rate, average weekly hours, factory orders
*Dates are indicative only and may change
MINI Trading Buy:
Source: IRESS
Lower risks plus attractive returns and upside from cyclical recovery
We continue to see risk mitigation and risk management in contract pricing as a core UGL competency. With only 8% of
the order book effectively exposed to lump sum fixed-price projects, there is lower sector risk than for major peers. A
portfolio of engineering and asset services offer attractive EPS growth prospects beyond FY10F and FY09 wins should
fuel future earnings growth, supported by the robust order book of A$9.3bn.
Source: IRESS
BXB’s AGM trading update showed underlying group revenue down 3% on the pcp, with CHEP and Recall both recording
3% declines. Given the weak economic conditions through the period to October we think this was not a bad outcome.
Outlook commentary suggests conditions remain weak with BXB yet to see a pickup in activity in its key US and
European markets.
CHEP
With a 5% decline in revenue, the CHEP Americas business was slightly weaker than expected. A soft US market was
the primary driver, with management now estimating pallet issues in the US will be 3% below FY09. CHEP EMEA
declined 1% (+1% ex-autos), while CHEP Asia Pacific increased 2% (+4% exautos) reflecting the better economic
environment in the region.
Source: IRESS
The scenario for an increase in 1H10F DPS to 15c is improving, in our view.
Sector performance
Banks' PE relative (to All Ords) is back down to 86%, having underperformed the market over the last month. While this is
above the long-run average, given short-term structural advantages, we believe the sector can trade at a premium. The
banks are now trading at an average PE of 13.5x FY10F on IBES consensus.
Investment view – RBS Research prefer ANZ and NAB to WBC and CBA
As a result of a normalising earnings cycle, we believe relative valuation will again play a significant role in the relative
performance of stocks in the sector. RBS believe ANZ and NAB still have the greater share price upside potential over
the next six to 12 months, given their 1-2 PE point discounts.
For further information please do not hesitate to contact us on the details below
Contact
Equities Structured Products & Warrants
Toll free 1800 450 005 www.rbs.com.au/warrants
Trading Products Team
Ben Smoker 02 8259 2085 ben.smoker@rbs.com
Ryan Corrigan 02 8259 2425 ryan.corrigan@rbs.com
Investment Products Team
Elizabeth Tian 02 8259 2017 elizabeth.tian@rbs.com
Tania Smyth 02 8259 2023 tania.smyth@rbs.com
Robert Deutsch 02 8259 2065 robert.deutsch@rbs.com
Mark Tisdell 02 8259 6951 mark.tisdell@rbs.com
Disclaimer:
The information contained in this report has been prepared by RBS Equities (Australia) Limited (“RBS”) (ABN 84 002 768 701) (AFS Licence No
240530) (“RBS Equities”) and has been taken from sources believed to be reliable. RBS Equities does not make representations that the information is
accurate or complete and it should not be relied on as such. Any opinions, forecasts and estimates contained in this report are the views of RBS
Equities at the date of issue and are subject to change without notice. RBS Equities and its affiliated companies may make markets in the securities
discussed. RBS Equities, its affiliated companies and their employees from time to time may hold shares, options, rights and warrants on any issue
contained in this report and may, as principal or agent, sell such securities. RBS Equities may have acted as manager or co-manager of a public
offering of any such securities in the past three years. RBS Equities’ affiliates may provide, or have provided banking services or corporate finance to
the companies referred to in this report. The knowledge of affiliates concerning such services may not be reflected in this report. This report does not
constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or commitment. RBS Equities,
in preparing this report, has not taken into account an individual client’s investment objectives, financial situation or particular needs. Before a client
makes an investment decision, a client should, with or without RBS Equities’ assistance, consider whether any advice contained in this report is
appropriate in light of their particular investment needs, objectives and financial circumstances. It is unreasonable to rely on any recommendation
without first having consulted with your adviser for a personal securities recommendation. This information contained in this report is general advice
only. RBS Equities, its officers, directors, employees and agents accept no liability for any loss or damage arising out of the use of all or any part of the
information contained in this report. This Information is not intended for distribution to, or use by any person or entity in any jurisdiction or country where
such distribution or use would be contrary to local law or regulation. If you are located outside Australia and use this Information, you are responsible
for compliance with applicable local laws and regulation. This report may not be taken or distributed, directly or indirectly into the United States, or to
any U.S. person (as defined in Regulation S under the U.S. Securities Act of 1993, as amended.
The warrants contained in this report are issued by RBS Group (Australia) Pty Limited (ABN 78 000 862 797, AFS Licence No. 247013). The Product
Disclosure Statements relating to these warrants are available upon request from RBS Equities or on our website www.rbs.com.au/warrants